HMGCR and polymyositis: When applying the ACR classification of 2017 in our study of nine patients, excluding the case of possible anti-HMGCR-positive IMNM, six cases with pathology (66.7%) and seven cases without pathology (77.8%) were classified as “polymyositis, including IMNM subgroups” in comparison to the ENMC classification.